Tag:
APT Pharmaceuticals
Latest Headlines
Latest Headlines
APT Pharma garners $32.5M to complete lung study
APT Pharmaceuticals has completed a $32.3 million Series B financing. The round was led by Three Arch Partners and joined by additional new investors InterWest Partners and Pinnacle Ventures.
APT lands $22M in first round
Burlingame, CA-based APT Pharmaceuticals has landed $22 million in series A-2 financing. New investors Versant Ventures and Great Point Partners joined existing firms Vivo Ventures and Charter Life
